US Bancorp’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $142K | Buy |
5,377
+584
| +12% | +$15.5K | ﹤0.01% | 2237 |
|
2025
Q1 | $116K | Buy |
4,793
+972
| +25% | +$23.5K | ﹤0.01% | 2324 |
|
2024
Q4 | $154K | Buy |
3,821
+9
| +0.2% | +$362 | ﹤0.01% | 2168 |
|
2024
Q3 | $241K | Sell |
3,812
-1,206
| -24% | -$76.4K | ﹤0.01% | 1937 |
|
2024
Q2 | $266K | Sell |
5,018
-1,924
| -28% | -$102K | ﹤0.01% | 1843 |
|
2024
Q1 | $569K | Buy |
6,942
+4,596
| +196% | +$377K | ﹤0.01% | 1423 |
|
2023
Q4 | $43.7K | Buy |
2,346
+937
| +67% | +$17.4K | ﹤0.01% | 2738 |
|
2023
Q3 | $15.6K | Sell |
1,409
-26,981
| -95% | -$299K | ﹤0.01% | 2985 |
|
2023
Q2 | $460K | Sell |
28,390
-5,879
| -17% | -$95.3K | ﹤0.01% | 1433 |
|
2023
Q1 | $571K | Sell |
34,269
-4,301
| -11% | -$71.6K | ﹤0.01% | 1337 |
|
2022
Q4 | $363K | Buy |
+38,570
| New | +$363K | ﹤0.01% | 1564 |
|
2021
Q4 | – | Sell |
-4,662
| Closed | -$29K | – | 4184 |
|
2021
Q3 | $29K | Sell |
4,662
-291
| -6% | -$1.81K | ﹤0.01% | 2927 |
|
2021
Q2 | $30K | Sell |
4,953
-49
| -1% | -$297 | ﹤0.01% | 2920 |
|
2021
Q1 | $32K | Buy |
5,002
+3,543
| +243% | +$22.7K | ﹤0.01% | 2799 |
|
2020
Q4 | $8K | Sell |
1,459
-2,466
| -63% | -$13.5K | ﹤0.01% | 3252 |
|
2020
Q3 | $23K | Sell |
3,925
-210
| -5% | -$1.23K | ﹤0.01% | 2729 |
|
2020
Q2 | $30K | Sell |
4,135
-108
| -3% | -$784 | ﹤0.01% | 2591 |
|
2020
Q1 | $20K | Buy |
4,243
+210
| +5% | +$990 | ﹤0.01% | 2694 |
|
2019
Q4 | $32K | Buy |
4,033
+46
| +1% | +$365 | ﹤0.01% | 2663 |
|
2019
Q3 | $27K | Sell |
3,987
-108
| -3% | -$731 | ﹤0.01% | 2727 |
|
2019
Q2 | $34K | Sell |
4,095
-56
| -1% | -$465 | ﹤0.01% | 2699 |
|
2019
Q1 | $41K | Buy |
+4,151
| New | +$41K | ﹤0.01% | 2582 |
|